145 related articles for article (PubMed ID: 23391162)
1. Structure-relaxivity relationships of serum albumin targeted MRI probes based on a single amino acid Gd complex.
Boros E; Caravan P
J Med Chem; 2013 Feb; 56(4):1782-6. PubMed ID: 23391162
[TBL] [Abstract][Full Text] [Related]
2. Serum albumin targeted, pH-dependent magnetic resonance relaxation agents.
Moriggi L; Yaseen MA; Helm L; Caravan P
Chemistry; 2012 Mar; 18(12):3675-86. PubMed ID: 22328098
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and evaluation of 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid derived, redox-sensitive contrast agents for magnetic resonance imaging.
Raghunand N; Guntle GP; Gokhale V; Nichol GS; Mash EA; Jagadish B
J Med Chem; 2010 Sep; 53(18):6747-57. PubMed ID: 20722424
[TBL] [Abstract][Full Text] [Related]
4. Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.
Boros E; Polasek M; Zhang Z; Caravan P
J Am Chem Soc; 2012 Dec; 134(48):19858-68. PubMed ID: 23157602
[TBL] [Abstract][Full Text] [Related]
5. Gd-complexes of macrocyclic DTPA conjugates of 1,1'-bis(amino)ferrocenes as high relaxivity MRI blood-pool contrast agents (BPCAs).
Kim HK; Park JA; Kim KM; Nasiruzzaman SM; Kang DS; Lee J; Chang Y; Kim TJ
Chem Commun (Camb); 2010 Nov; 46(44):8442-4. PubMed ID: 20886175
[TBL] [Abstract][Full Text] [Related]
6. Probing the structure-relaxivity relationship of bis-hydrated Gd(DOTAla) derivatives.
Boros E; Caravan P
Inorg Chem; 2015 Mar; 54(5):2403-10. PubMed ID: 25693053
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
[TBL] [Abstract][Full Text] [Related]
8. Ln[DO3A-N-α-(pyrenebutanamido)propionate] complexes: optimized relaxivity and NIR optical properties.
Ferreira MF; Pereira G; Martins AF; Martins CI; Prata MI; Petoud S; Toth E; Ferreira PM; Martins JA; Geraldes CF
Dalton Trans; 2014 Feb; 43(8):3162-73. PubMed ID: 24343660
[TBL] [Abstract][Full Text] [Related]
9. Noncovalent binding of some new lipophilic gadolinium DTPA complexes to human serum albumin. A structure-affinity relationship.
Laurent S; Vander Elst L; Henrotte V; Muller RN
Chem Biodivers; 2010 Dec; 7(12):2846-55. PubMed ID: 21161997
[TBL] [Abstract][Full Text] [Related]
10. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.
McMurry TJ; Parmelee DJ; Sajiki H; Scott DM; Ouellet HS; Walovitch RC; Tyeklár Z; Dumas S; Bernard P; Nadler S; Midelfort K; Greenfield M; Troughton J; Lauffer RB
J Med Chem; 2002 Aug; 45(16):3465-74. PubMed ID: 12139457
[TBL] [Abstract][Full Text] [Related]
11. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
12. Gd(DO3A-N-alpha-aminopropionate): a versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents.
Ferreira MF; Martins AF; Martins JA; Ferreira PM; Tóth E; Geraldes CF
Chem Commun (Camb); 2009 Nov; (42):6475-7. PubMed ID: 19841814
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and physicochemical characterization of two gadolinium(III) TTDA-like complexes and their interaction with human serum albumin.
Ou MH; Tu CH; Tsai SC; Lee WT; Liu GC; Wang YM
Inorg Chem; 2006 Jan; 45(1):244-54. PubMed ID: 16390062
[TBL] [Abstract][Full Text] [Related]
14. Facile synthesis of non-ionic dimeric molecular resonance imaging contrast agent: its relaxation and luminescence studies.
Tanwar J; Datta A; Tiwari AK; Chaturvedi S; Ojha H; Allard M; Chaudary NK; Thirumal M; Mishra AK
Dalton Trans; 2011 Apr; 40(13):3346-51. PubMed ID: 21347458
[TBL] [Abstract][Full Text] [Related]
15. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
16. Strategies for the covalent conjugation of a bifunctional chelating agent to albumin: synthesis and characterization of potential MRI contrast agents.
Kundu A; Peterlik H; Krssak M; Bytzek AK; Pashkunova-Martic I; Arion VB; Helbich TH; Keppler BK
J Inorg Biochem; 2011 Feb; 105(2):250-5. PubMed ID: 21194625
[TBL] [Abstract][Full Text] [Related]
17. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging.
Huang Y; Boamah PO; Gong J; Zhang Q; Hua M; Ye Y
Carbohydr Polym; 2016 Jun; 143():288-95. PubMed ID: 27083371
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Effect of Human Serum Albumin and Fullerene on Gd-DO3A for Tumor-Targeting Imaging.
Zhang Y; Zou T; Guan M; Zhen M; Chen D; Guan X; Han H; Wang C; Shu C
ACS Appl Mater Interfaces; 2016 May; 8(18):11246-54. PubMed ID: 27097822
[TBL] [Abstract][Full Text] [Related]
19. Gd(DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agents.
Boros E; Karimi S; Kenton N; Helm L; Caravan P
Inorg Chem; 2014 Jul; 53(13):6985-94. PubMed ID: 24922178
[TBL] [Abstract][Full Text] [Related]
20. High relaxivity Mn(2+)-based MRI contrast agents.
Regueiro-Figueroa M; Rolla GA; Esteban-Gómez D; de Blas A; Rodríguez-Blas T; Botta M; Platas-Iglesias C
Chemistry; 2014 Dec; 20(52):17300-5. PubMed ID: 25382711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
